[13C2,15N2]-Nilotinib

Nilotinib is an anticancer drug used to treat Philadelphia chromosome (Ph+)-positive chronic myelogenous leukemia (CML). It induces serious side effects such as QT prolongation, sudden death, pancreatitis, and liver problems.

Stable isotope labeled [¹³C₂,¹⁵N₂]-Nilotinib is intended for use as an internal standard for the quantification of Nilotinib by LC or GC-mass spectrometry.